Log in to search using one of your social media accounts:

 

Does Chagas disease present a health risk to Canadians?
(McGill University Health Centre) Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas -- the 'Kissing Bug' disease -- is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal. Experts from Winnipeg and Montreal warn natives of Latin America and their offspring are at risk of contracting Chagas disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 13, 2017 Category: Infectious Diseases Source Type: news

Drug blocks Zika and dengue viruses in study
The small-molecule inhibitor, named NGI-1, shows promise as a treatment for Zika, dengue, West Nile, and yellow fever viruses. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 12, 2017 Category: Universities & Medical Training Source Type: news

Mosquito sex protein could provide key to controlling disease
(Rockefeller University) A protein transferred from male to female mosquitoes during sex influences female mating behavior -- a phenomenon that could be exploited to limit the spread of mosquito-borne illnesses like Zika and dengue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2017 Category: International Medicine & Public Health Source Type: news

How Zika virus induces congenital microcephaly
(Institut Pasteur) Epidemiological studies show that in utero fetal infection with the Zika virus (ZIKV) may lead to microcephaly, an irreversible congenital malformation of the brain characterized by an incomplete development of the cerebral cortex. However, the mechanism of Zika virus-associated microcephaly remains unclear. An international team of researchers within the European consortium ZIKAlliance (coordinated by Inserm in France) has identified a specific mechanism leading to this microcephaly. Their findings are published this week in Nature Neuroscience. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2017 Category: International Medicine & Public Health Source Type: news

New model for Zika developed to aid in testing vaccines and treatments
(Texas Biomedical Research Institute) An alternative animal model that mimics key features of the Zika virus infection, including its lingering presence in bodily fluids, has been developed at Texas Biomedical Research Institute in San Antonio. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 11, 2017 Category: Infectious Diseases Source Type: news

YSPH responds to Brazil's microcephaly crisis
Thanks to the spread of the Zika virus, microcephaly has been on the rise in Brazil. Yale researchers have been instrumental to helping contain it. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 6, 2017 Category: Universities & Medical Training Source Type: news

Finches, Dogs, Lions and Zika: An Ecologist Looks at Emerging Disease
University of Minnesota, School of Public Health. 01/24/2017 This one-hour, 32-minute webinar provides quantitative estimates of levels of pathogen diversity in natural communities, illustrating the relative insignificance of discovering new viruses, and describing the factors that determine successful emergence and subsequent evolution in a well-studied avian pathogen. The speaker also provides an analysis of the current and future dynamics of Zika virus and its response to potential control methods. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - December 6, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Zika vaccine shows promise in early clinical tests
A new Zika vaccine induced an immune response in a trio of early clinical trials, according to the National Institutes of Health. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 5, 2017 Category: Consumer Health News Source Type: news

Gene-Based Zika Vaccine is Safe and Immunogenic in Healthy Adults
Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults. (Source: PHPartners.org)
Source: PHPartners.org - December 5, 2017 Category: International Medicine & Public Health Source Type: news

Gene-based Zika vaccine is safe and immunogenic in healthy adults
Vaccine developed by NIH scientists shows promise in Phase 1 testing. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 5, 2017 Category: American Health Source Type: news

Gene-based Zika vaccine is safe and immunogenic in healthy adults
Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults. The findings will be published on Dec. 4 in The Lancet. NIAID is currently leading an international effort to evaluate the investigational vaccine in a Phase 2/2b safety and efficacy trial. (Source: World Pharma News)
Source: World Pharma News - December 5, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Army-developed Zika vaccine induces strong immune response in three phase 1 studies
(Walter Reed Army Institute of Research) Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Initial findings from the trials were published today in The Lancet. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 5, 2017 Category: Biology Source Type: news

Researchers show how insect food choice can be manipulated
(University of California - Riverside) Researchers at the University of California, Riverside have found a way to access and manipulate taste neurons in the pharynx (throat) of the common fruit fly that could help control the spread of mosquito-related illnesses, such as dengue, malaria, yellow fever, and Zika virus, and reduce the loss of crops due to agricultural pests. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 5, 2017 Category: Infectious Diseases Source Type: news

Good news from trio of phase one Zika vaccine trials
(Saint Louis University) More than 90 percent of study volunteers in the 3 trials who received the investigational vaccine demonstrated an immune response to Zika virus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2017 Category: International Medicine & Public Health Source Type: news

Trial results of Zika vaccine Sanofi dropped show promise
CHICAGO (Reuters) - A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Trials show inactivated Zika virus vaccine is safe and immunogenic
Results support further clinical development. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 4, 2017 Category: American Health Source Type: news

FDA Panel Recommends Zika Testing of Donated Blood Be Relaxed FDA Panel Recommends Zika Testing of Donated Blood Be Relaxed
Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be relaxed due to diminished risk of transfusion-transmitted infection.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 4, 2017 Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news

Trials show inactivated Zika virus vaccine is safe and immunogenic
(NIH/National Institute of Allergy and Infectious Diseases) The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials. Scientists at the Walter Reed Army Institute of Research (WRAIR) are developing the vaccine and leading one of the trials. WRAIR also is co-funding the trials with the National Institute of Allergy and Infectious Diseases, part of NIH. The results will appear in The Lancet. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 4, 2017 Category: Infectious Diseases Source Type: news

Gene-based Zika vaccine is safe and immunogenic in healthy adults
(NIH/National Institute of Allergy and Infectious Diseases) Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults. The findings will be published on Dec. 4 in The Lancet. NIAID is currently leading an international effort to evaluate the investigational vaccine in a Phase 2/2b safety and efficacy trial. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 4, 2017 Category: Infectious Diseases Source Type: news

Zika vaccine induces robust immune responses in three phase 1 trials
(Beth Israel Deaconess Medical Center) Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo-controlled, double-blind trials conducted at Beth Israel Deaconess Medical Center (BIDMC), Walter Reed Army Institute of Research (WRAIR), and Saint Louis University School of Medicine. The findings were published today in The Lancet. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 4, 2017 Category: Infectious Diseases Source Type: news

FDA panel recommends Zika testing of donated blood be relaxed
(Reuters) - Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be relaxed due to diminished risk of transfusion-transmitted infection. (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Red Book: Zika Chapter
American Academy of Pediatrics. 11/30/2017 This Web page provides a new Red Book chapter on Zika that was released ahead of the full 2018 Report of the Committee on infectious Diseases. The chapter provides information on Zika's clinical manifestations, etiology, epidemiology, control measures, and diagnostic tests, as well as guidance on managing infants who have been exposed. It includes guidance from the Centers for Disease Control and Prevention, much of which was created with input from American Academy of Pediatrics experts and updated in October. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - December 1, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Increasing Access to Contraception During Zika Response Increasing Access to Contraception During Zika Response
What strategies are being used by state and local health agencies to implement increased access to contraceptive services in the wake of the Zika virus outbreak?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Zika Virus and Your Eyes
Prevent Blindness. 10/18/2017 This one-hour webinar discusses the Zika virus, and how it affects vision in babies whose mothers were infected with the virus during pregnancy and in infants diagnosed with congenital Zika syndrome. It provides information about how professionals working with expectant mothers and parents of babies with congenital Zika syndrome can provide direct support and increase access to supportive services for vision impairment and low vision services. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 30, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Evaluation for Infants with Possible Congenital Zika Infection
Centers for Disease Control and Prevention. 10/19/2017 This two-page document provides an algorithm for evaluating infants with possible congenital Zika infection, starting with asking about possible maternal Zika exposure. It details steps to take depending on whether an infant has findings consistent with congenital Zika syndrome. It includes a table on interpretation of results of laboratory testing of infant's blood, urine, and/or cerebrospinal fluid for evidence of congenital Zika virus infection. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 30, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Takeda moves ahead in Zika race with launch of vaccine trial
LONDON (Reuters) - Japan's Takeda Pharmaceutical has moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government. (Source: Reuters: Health)
Source: Reuters: Health - November 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Global Health Is a Cause We Can All Get Behind
November 27, 2017None of us can afford to ignore the plights of other countries.“What is IntraHealth anyway?”A woman asked this as she approached our booth at aState Employees Combined Campaign event this year, where people who want to donate to good causes can connect to the organizations behind them. At first, I was glad she asked.“IntraHealth International is a nonprofit based in Chapel Hill and our focus is on health workers,” I said. “We believe—”“Health workers in America?”“No,” I said, “our work is primarily international. We currently work in 3...
Source: IntraHealth International - November 27, 2017 Category: International Medicine & Public Health Authors: mnathe Source Type: news

Zika Nerve Damage May Stem From Virus Response
Nerve-related complications of Zika infection may be caused by the immune system's response to the virus, not the virus itself, according to a new study. (Source: WebMD Health)
Source: WebMD Health - November 27, 2017 Category: Consumer Health News Source Type: news

Zika Nerve Damage May Stem From Body's Response to the Virus
MONDAY, Nov. 27, 2017 -- Nerve-related complications of Zika infection may be caused by the immune system's response to the virus, not the virus itself, according to a new study. Zika is spread primarily via the bite of an infected mosquito, but it... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 27, 2017 Category: General Medicine Source Type: news

Preventing and Managing Congenital Zika and Congenital Syphilis Infections
Johns Hopkins University, Bloomberg School of Public Health, MidAtlantic Public Health Training Center. 07/27/2017 This on-demand webinar provides health care providers with information on prevention, diagnosis, and treatment of Zika and syphilis infections to address the emerging crisis of congenital Zika virus and the increasing number of congenital syphilis cases nationally and regionally. It describes the epidemiology and risk factors for congenital syphilis and congenital Zika syndrome, and discusses the difficulties of diagnosis of both diseases. (Video or Multimedia) Site requires free registration. (Source: Disaste...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 22, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Rainfall can indicate that mosquito-borne epidemics will occur weeks later
FINDINGSA new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall.Researchers also found that Chikungunya will predominate over Zika when both circulate at the same time, because Chikungunya has a shorter incubation period — just two days, versus 10 days for Zika. The latter finding explains why a late-2015 Zika epidemic in Rio de Janeiro ended while the number of Chikungunya cases increased in February 2016.BACKGROUNDViruses transmitted by insects can lead to serious health repercussions. Zika is linked to birth defects, and up to 1 ...
Source: UCLA Newsroom: Health Sciences - November 21, 2017 Category: Universities & Medical Training Source Type: news

Rainfall can indicate that mosquito-borne epidemics will occur weeks later
(University of California - Los Angeles Health Sciences) A new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall. Researchers also found that Chikungunya will predominate over Zika when both circulate at the same time. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 21, 2017 Category: Infectious Diseases Source Type: news

Zika-related nerve damage caused by immune response to the virus
The immune system ’s response to the Zika virus may be responsible for nerve-related complications of infection, according to a Yale study. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 20, 2017 Category: Universities & Medical Training Source Type: news

Assessing Zika Risk in International Travelers Assessing Zika Risk in International Travelers
Travelers need to be educated about their risks and decide which they are willing to accept.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2017 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Evaluation of Five Commercial Zika Virus Immunoassays Evaluation of Five Commercial Zika Virus Immunoassays
The authors compare the sensitivity and specificity of several diagnostic immunoassays for Zika virus. How do they measure up?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2017 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Zika-related nerve damage caused by immune response to the virus
(Yale University) The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients with Zika-related complications, such as Guillain-Barr é syndrome, the researchers said. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 20, 2017 Category: Infectious Diseases Source Type: news

Florida confirms second local Zika virus infection for 2017
Florida health officials report state's 2nd case this year of the Zika virus transmitted by a local mosquito (Source: ABC News: Health)
Source: ABC News: Health - November 17, 2017 Category: Consumer Health News Tags: Health Source Type: news

Anti-malaria drug shows promise as Zika virus treatment
(Sanford-Burnham Prebys Medical Discovery Institute) California researchers have discovered that a medication used to prevent and treat malaria may also be effective for Zika virus. The drug, called chloroquine, has a long history of safe use during pregnancy, and is relatively inexpensive. The research was published today in Scientific Reports. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 17, 2017 Category: Infectious Diseases Source Type: news

'The Brazilian Zika outbreak could end soon'
(German Center for Infection Research) Scientists have elucidated the Zika burden in a Brazilian metropolis. Their data indicate: the outbreak may be coming to an end and further outbreaks in the region seem unlikely. The study has also provided new evidence supporting the link between Zika infection during pregnancy and malformations in newborns. A third finding is important with regard to intervention measures: Zika virus infection predominantly affects poor regions. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 16, 2017 Category: Infectious Diseases Source Type: news

Prior asymptomatic zika infection protects against reinfection in pregnant mice
(PLOS) Protective antibodies from prior asymptomatic Zika infection defend against reinfection during pregnancy in mice, according to new research published in PLOS Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 16, 2017 Category: Infectious Diseases Source Type: news

Study raises possibility of naturally acquired immunity against Zika virus
(Cincinnati Children's Hospital Medical Center) Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it. New research in PLOS Pathogens on Nov. 16, performed in mice, shows women who develop symptom-free Zika infections may be able to acquire immunity that would protect them from future infections and their offspring in a future pregnancy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 16, 2017 Category: Infectious Diseases Source Type: news

Evolution of neurovirulent Zika virus
(Source: ScienceNOW)
Source: ScienceNOW - November 16, 2017 Category: Science Authors: Screaton, G., Mongkolsapaya, J. Tags: Epidemiology perspective Source Type: news

A single mutation in the prM protein of Zika virus contributes to fetal microcephaly
Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly. Phylogenetic analysis reveals that contemporary epidemic strains have accumulated multiple substitutions from their Asian ancestor. Here we show that a single serine-to-asparagine substitution [Ser139->Asn139 (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice. Evolutionary analysis indicates that the S139N substitution arose b...
Source: ScienceNOW - November 16, 2017 Category: Science Authors: Yuan, L., Huang, X.-Y., Liu, Z.-Y., Zhang, F., Zhu, X.-L., Yu, J.-Y., Ji, X., Xu, Y.-P., Li, G., Li, C., Wang, H.-J., Deng, Y.-Q., Wu, M., Cheng, M.-L., Ye, Q., Xie, D.-Y., Li, X.-F., Wang, X., Shi, W., Hu, B., Shi, P.-Y., Xu, Z., Qin, C.-F. Tags: Epidemiology reports Source Type: news

Zika, Dengue and Chikungunya Prevention Toolkit
International Federation of Red Cross and Red Crescent Societies. 04/18/2017 This 55-page toolkit is intended to be used with the Zika, dengue, and chikungunya prevention training modules for communities and schools/youth. It features full-color imagery, interactive formats, and games material to teach all audiences according to the methodology suggested in the module guides. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Zika, Dengue and Chikungunya Prevention Community Module
International Federation of Red Cross and Red Crescent Societies. 04/18/2017 This 56-page module is intended for volunteers teaching and coaching adults about the transmission, symptoms, treatment, and prevention methods to address Zika, dengue, and chikungunya. It is comprised of five topics that are recommended for teaching in sequential order for maximum effect. The materials also address stigma associated with these diseases, and help to set a supportive environment for preventing disease as a collective group through ongoing community action. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Zika, Dengue and Chikungunya Prevention School/Youth Module
International Federation of Red Cross and Red Crescent Societies. 04/18/2017 This 56-page module is intended for volunteers, educators, and peer educators teaching children from ages 7 to 16 in a school or youth club setting about the transmission, symptoms, treatment, and prevention methods to address Zika, dengue, and chikungunya. The youth module is comprised of five topics that should be taught in sequential order. The materials also address stigma associated with these diseases, and help to set a supportive environment for preventing disease as a collective group through ongoing school community action. (PDF) (Source:...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Responding to Global Health Security Threats
PATH. 07/2017 This three-page document outlines threats to global health security and the case for investment and action to keep Americans safe. It discusses Ebola, Zika, and pandemic flu as examples of emerging infectious diseases and pandemic threats that historically impacted other geographies but now directly endanger American health. It details recommendations for leveraging the nation's deep technical expertise in pandemic preparedness and response so the U.S. will remain a key player in handling global threats. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Vector Control with a Focus on Aedes Aegypti and Aedes Albopictus Mosquitoes: Literature Review and Analysis
European Union, European Centre for Disease Prevention and Control. 10/16/2017 This 63-page report describes a literature review of the currently recommended vector control measures in Europe against Aedes aegypti and Aedes albopictus mosquitoes, which are vectors for chikungunya, dengue, and Zika viruses. The main gaps identified were in relation to evaluation, sustainability, and community engagement. The report identifies key areas where there is a lack of information and where opportunities exist to further enhance vector control across Europe. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Three decades of responding to infectious disease outbreaks
NIAID director Anthony S. Fauci, M.D., highlights lessons from AIDS to Zika. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 14, 2017 Category: American Health Source Type: news

Dengue immunity can protect against Zika virus
(La Jolla Institute for Allergy and Immunology) A study published the Nov. 13, 2017, issue of Nature Communications by La Jolla Institute for Allergy and Immunology (LJI) investigator Sujan Shresta, Ph.D., now addresses interplay between dengue and ZIKV infections. It reports that mice rendered immune to dengue show 'cross-protection' from subsequent Zika infection and then identifies specific types of immune T-cells capable of defending against both viruses. These revelations have profound implications for efforts to build a potent anti-Zika vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news